The LUNGevity Early Lung Cancer Center (ELCC) Multistakeholder Meeting enables leaders from across the lung cancer community to come together and advance solutions that ensure patients are found early and can benefit from the numerous innovations that directly contribute to survivorship. The ELCC is creating an integrated approach across detection, diagnosis and treatment to address areas of greatest impact and progress through our multistakeholder working groups, initiatives and policy coalition.

Like last year's meeting, this event will be professionally moderated and include break-out time for working groups to meet in person. We are excited to offer another hands-on, workshop-style experience that relies on your active participation. Agenda highlights are:

Working Group Updates:

• No Nodule Left Behind=> origin and success stories of Incidental Pulmonary Nodule (IPN) programs
• Value Proposition=> building communication between clinical champions and business champions
• MDT Care in the Early-Stage Setting=> leveraging points of interception to educate on the importance of medical oncology consultation for eligible patients
• Common themes analysis=> shared success factors across all working groups (e.g., outreach and dissemination strategies; importance of building champions)

Additional Key Topics:

• Policy Coalition Update=> summary of priority issues and activities to date
• Expanding the Guidelines, Does the Data Support it? evidence synthesis of current screening eligibility data in non-guideline-inclusive populations=> Findings/Recommendations
• Early-State Patient panel=> addressing the needs of the early-stage population and understanding their role in the advocacy landscape
• The Role of AI in Lung Cancer=> will AI enable prediction prior to detection?

ELCC and the working groups are tackling barriers rooted in workflow, implementation and communication that are driven by "in the trenches leadership." Your contributions are enabling progress that benefits patients today.

So, join us April 17 & 18 to continue to advance solutions that will have an impact.